An Official publication of The Asian Congress of Neurological Surgeons (AsianCNS)

Search Article
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Advertise Subscribe Contacts Login  Facebook Tweeter
  Users Online: 1025 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Therapeutic evaluation of tumor necrosis factor-alpha antagonist etanercept against traumatic brain injury in rats: Ultrastructural, pathological, and biochemical analyses

Hasturk Askin Esen, Gokce Emre Cemal, Yilmaz Erdal Resit, Horasanli Bahriye, Evirgen Oya, Hayirli Nazli, Gokturk Hilal, Erguder Imge, Can Belgin

Year : 2018| Volume: 13| Issue : 4 | Page no: 1018-1025

   This article has been cited by
1 Phase I/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation
Stephen J. Ralph,Andrew Weissenberger,Ventzislav Bonev,Liam D. King,Mikaela D. Bonham,Samantha Ferguson,Ashley D. Smith,Adrienne A. Goodman-Jones,Anthony J. Espinet
Expert Opinion on Investigational Drugs. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Microglial Depletion Causes Region-Specific Changes to Developmental Neuronal Cell Death in the Mouse Brain
Andrew J. Jacobs,Alexandra Castillo-Ruiz,Carla D. Cisternas,Nancy G. Forger
Developmental Neurobiology. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6'-Dithiothalidomide on Traumatic Brain Injury
Buyandelger Batsaikhan,Jing-Ya Wang,Michael Scerba,David Tweedie,Nigel Greig,Jonathan Miller,Barry Hoffer,Chih-Tung Lin,Jia-Yi Wang
International Journal of Molecular Sciences. 2019; 20(3): 502
[Pubmed]  [Google Scholar] [DOI]


Read this article